← All companies

GLMD

Galmed Pharmaceuticals Ltd.

GLMD Nasdaq Pharmaceutical Preparations EDGAR ↗

$0.59

-0.01 -2.34%

Key statistics

from XBRL data in SEC filings

Market cap

$3.85M

Revenue (TTM)

$0.00

Net income (TTM)

-$10.3M

EPS (TTM)

$2.39

P/E ratio

0.2

Dividend yield

—

Free cash flow

-$6.32M

Cash

$3.98M

Total assets

$18.6M

Gross margin

—

52-week range

$0.41 – $1.70

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jul 31, 2026 6-K Jul 29, 2026 6-K Jul 28, 2026 6-K Jul 22, 2026 6-K Jul 16, 2026 6-K Jul 8, 2026 6-K Jun 22, 2026 6-K Jun 8, 2026 6-K Jun 2, 2026 6-K May 14, 2026 6-K May 6, 2026 6-K Apr 14, 2026 6-K Apr 9, 2026 20-F Mar 31, 2026 6-K Mar 5, 2026 6-K Mar 4, 2026 6-K Feb 9, 2026 6-K Jan 30, 2026 6-K Dec 8, 2025 6-K Dec 4, 2025 6-K Dec 1, 2025 6-K Nov 26, 2025 6-K Nov 18, 2025 6-K Nov 17, 2025 6-K Oct 29, 2025 6-K Oct 28, 2025 6-K Sep 19, 2025 6-K Aug 28, 2025 6-K Aug 25, 2025 6-K Aug 15, 2025 6-K Aug 14, 2025 6-K Jul 24, 2025 6-K May 27, 2025 6-K May 22, 2025 6-K May 13, 2025 6-K May 6, 2025 6-K Apr 28, 2025 6-K Apr 17, 2025 6-K Apr 15, 2025 6-K Apr 10, 2025